Strategic Partnerships
We are partnering with pharmaceutical companies who have developed second generation antiandrogens that are approved for the treatment of prostate cancer. ESSA is currently collaborating with Janssen Research & Development, LLC (Janssen), Astellas Pharma Inc. (Astellas), and Bayer to evaluate EPI-7386 in combination with these companies’ antiandrogen treatments in Phase 1/2 trials.